Evidence map›Paper›PMID 25272951›Full record

ArticleAnnals of neurology2014

A new muscle glycogen storage disease associated with glycogenin-1 deficiency.

Edoardo Malfatti, Johanna Nilsson, Carola Hedberg-Oldfors, Aurelio Hernandez-Lain, Fabrice Michel, Cristina Dominguez-Gonzalez, Gabriel Viennet, H Orhan Akman, Cornelia Kornblum, Peter Van den Bergh and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03642860 (Triheptanoin's Effect on Fatty Acid Oxidation and Exercise Tolerance in Patients With Debrancher Deficiency, Glycogenin-1 Deficiency and Phosphofructoinase Deficiency at Rest and During Exercise. A Randomized, Double-blind, Placebo-controlled, Cross-over Study), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03642860 phase2completednot on this mapstarted 2018, after this paper: background citation

Triheptanoin's Effect on Fatty Acid Oxidation and Exercise Tolerance in Patients With Debrancher Deficiency, Glycogenin-1 Deficiency and Phosphofructoinase Deficiency at Rest and During Exercise. A Randomized, Double-blind, Placebo-controlled, Cross-over Study

TypeinterventionalSponsorRigshospitalet, DenmarkRan2018 to 2019Enrolled3ConditionsTarui Disease, Debrancher Deficiency, GYG1 DEFICIENCYArmsTriheptanoin, Placebo Oil
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Neurological glycogen storage diseases and emerging therapeutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  7. Review
  8. New mutations identified in a case of Glycogenin-1 deficiency.Molecular genetics and metabolism reports · 2024
    Article
  9. Gene therapy for glycogen storage diseases.Journal of inherited metabolic disease · 2024
    Review
  10. Glycogen storage diseases.Nature reviews. Disease primers · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Differential diagnosis of vacuolar myopathies in the NGS era.Brain pathology (Zurich, Switzerland) · 2020
    Article
  17. Glycogenin-1 deficiency mimicking limb-girdle muscular dystrophy.Molecular genetics and metabolism reports · 2020
    Article
  18. JIMD reports · 2020
    Article
  19. Article
  20. Update on polyglucosan storage diseases.Virchows Archiv : an international journal of pathology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 6 countries.

Edoardo MalfattiDepartment of Pathology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Myology Institute, Neuromuscular Morphology Unit, Pierre and Marie Curie University, Pitié-Salpêtrière University Hospital Group, Sorbonne Universities, Paris, France.
Johanna Nilsson
Carola Hedberg-Oldfors
Aurelio Hernandez-Lain
Fabrice Michel
Cristina Dominguez-Gonzalez
Gabriel Viennet
H Orhan Akman
Cornelia Kornblum
Peter Van den Bergh
Norma B Romero
Andrew G Engel
Salvatore DiMauro
Anders Oldfors
University of Gothenburg · SECentre Hospitalier Universitaire de Besançon · FRColumbia University Irving Medical Center · USHospital Universitario 12 De Octubre · ESCliniques Universitaires Saint-Luc · BEInstitut de Myologie · FRMayo Clinic · USSorbonne Université · FRUniversity Hospital Bonn · DE

Funding

ELECTRON MICROSCOPY OF MYOPATHIESR01NS006277 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE · 1985 to 2015
$7.8M
Congenital Myasthenic SyndromesR56NS006277 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE, SELCEN, DUYGU · 2017 to 2017
$539k
NINDS NIH HHS NS6277NINDS NIH HHS R01 NS006277NINDS NIH HHS R56 NS006277
6 · The paper itself

Abstract

We describe a slowly progressive myopathy in 7 unrelated adult patients with storage of polyglucosan in muscle fibers. Genetic investigation revealed homozygous or compound heterozygous deleterious variants in the glycogenin-1 gene (GYG1). Most patients showed depletion of glycogenin-1 in skeletal muscle, whereas 1 showed presence of glycogenin-1 lacking the C-terminal that normally binds glycogen synthase. Our results indicate that either depletion of glycogenin-1 or impaired interaction with glycogen synthase underlies this new form of glycogen storage disease that differs from a previously reported patient with GYG1 mutations who showed profound glycogen depletion in skeletal muscle and accumulation of glycogenin-1.

Indexed as

AdultAgedFemaleGlucosyltransferasesGlycogen Storage DiseaseGlycogen SynthaseGlycoproteinsHumansMaleMiddle AgedMuscle, SkeletalGlucosyltransferasesglycogeninGlycogen SynthaseGlycoproteins

Identifiers

PMID25272951
PMCPMC4348070
OpenAlexW2138270288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.